PRL-2 expression was shown previously to correlate with cancer progression (3, 35), and PRLs were demonstrated recently to interact with CNNMs to promote oncogenesis by regulating intracellular levels of magnesium (5, 9). The gene discussed is PTP4A2; the disease is cancer.